H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

H1N1 vaccine updates from Pennsylvania Department of Health

H1N1 vaccine updates from Pennsylvania Department of Health

New N95 respirator from Safe Life

New N95 respirator from Safe Life

Novartis to acquire 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical for US$125 million

Novartis to acquire 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical for US$125 million

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

NanoViricides to present data on its in vivo studies against influenza

NanoViricides to present data on its in vivo studies against influenza

Cellular mechanisms that may impact immune functions in the elderly discovered

Cellular mechanisms that may impact immune functions in the elderly discovered

Transatlantic task force to address antibiotic resistance established, experts welcome initiative

Transatlantic task force to address antibiotic resistance established, experts welcome initiative

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance

2009 H1N1 influenza PPE federal guidance for healthcare workers causes concern among prevention experts

2009 H1N1 influenza PPE federal guidance for healthcare workers causes concern among prevention experts

Prestige Ameritech to open a Global Pandemic Preparedness and Response Center

Prestige Ameritech to open a Global Pandemic Preparedness and Response Center

Poll examines the American public's response to H1N1 vaccine shortage

Poll examines the American public's response to H1N1 vaccine shortage

55% of adult population in Greater Washington, DC say they will not get  H1N1 flu vaccine, reveals poll results

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

H1N1 is now most dominant flu strain worldwide, WHO says

H1N1 is now most dominant flu strain worldwide, WHO says

Preparis unveils new website to help businesses and employees prepare for swine flu pandemic

Preparis unveils new website to help businesses and employees prepare for swine flu pandemic

Volunteers from Charlotte provide community service at 38 locations

Volunteers from Charlotte provide community service at 38 locations

Eggs sensitivity and flu shot: Doctors' dilemma

Eggs sensitivity and flu shot: Doctors' dilemma

H1N1 Contingency Plan for business associations

H1N1 Contingency Plan for business associations

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.